Skip to main content

Biolife Solutions Inc

BLFS
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0000834365

No open-market purchases or sales by Biolife Solutions Inc insiders were filed in the last 90 days; 216 institutions reported holding it in 13F filings for Q2 2026, worth $1.40B in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Biolife Solutions Inc changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of BLFS: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders169156−13
Shares38.8M40.6M+1.79M (+4.6%)
Value$842.8M$896.7M+$53.9M (+6.4%)

New holders (9)

Institutions that held Biolife Solutions Inc at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to BLFS in Q2 2023
InstitutionSharesValue% of portfolio
Hood River Capital Management LLC389,522$8.61M0.26%
Balyasny Asset Management LLC63,691$1.41M0.00%
Nine Ten Capital Management LLC38,577$853.0K0.29%
Jane Street Group, LLC22,497$497.2K0.00%
Channing Capital Management, LLC20,106$444.3K0.01%
Caption Management, LLC7,035$155.5K0.03%
Harbor Capital Advisors, Inc.978$21.6K0.00%
Bollard Group LLC258$6.00K0.00%
Foster Dykema Cabot & Co Inc177$4.00K0.00%

Sold out (22)

Institutions that held Biolife Solutions Inc at the end of Q1 2023 and filed for Q2 2023 without it.